1. Home
  2. Vol 17, No 2 (2023)
  3. Putri

Characteristics of Lung Cancer Patients at Dr. Soedarso Hospital Pontianak from 2017 to 2019

Agusriani Putri, Sari Eka Pratiwi, Risa Febriana Musawaris

Abstract


Background: Lung cancer is the second most commonly diagnosed malignancy and the leading cause of death in 2020. Preliminary studies from 2014 to 2019 at Dr. Soedarso Hospital Pontianak showed there was an increase in lung cancer cases. This study aimed to determine the clinical profile of patients with lung cancer in Dr. Soedarso Hospital

Methods: This epidemiological study used medical records from patients diagnosed with lung cancer at Dr. Soedarso Hospital Pontianak from 2017 to 2019. It was a cross-sectional study, and 81 samples met the criteria. The inclusion criteria are the completeness of data and the results of cytopathology laboratory examinations. The data were processed using Microsoft Excel.

Results: In this study, based on the characteristics of patients diagnosed with lung cancer in Dr. Soedarso Hospital, 82.7% are male with an average diagnosed age of 54.8 years, and 72.8% of patients do not have a smoking history. The common symptoms of patients are shortness of breath (77.8%), chest pain (55.6%), and weight loss (30.9%). The most common type is Non-Small Cell Lung Carcinoma (NSCLC) specifically Adenocarcinoma (76.5%).

Conclusion: This study shows that lung cancer incidence in males was higher than in females, and most patients diagnosed did not have a smoking history. The most common symptom of patients is shortness of breath with the most common type of cytopathology results being adenocarcinoma.


Keywords


cytopathological results, lung cancer, patient characteristics

Full Text: View | Download

DOI: 10.33371/ijoc.v17i2.950

Article Metrics

Abstract View: 1832,
PDF Download: 618
             

References


Wijaya CA, Muchtaridi M. Pengobatan Kanker Melalui Metode Gen Terapi. Farmaka. 2017;15(1):53–68.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances since the 2004 Classification. J Thorac Oncol. 2015;10(9):1240-2.

Hasanovic A, Rekhtman N, Sigel CS, Moreira AL. Advances in Fine Needle Aspiration Cytology for the Diagnosis of Pulmonary Carcinoma. Patholog Res Int. 2011;2011:1–7.

Hulma MA, Basyar M, Mulyani H. Hubungan Karakteristik Penderita dengan Gambaran Sitopatologi pada Kasus Karsinoma Paru yang Dirawat di RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2014;3(2):196–201.

Kementerian Kesehatan Republik Indonesia. Pedoman nasional penanganan kanker paru. Komite Penanggulangan Kanker Nasional. 2017.

Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41(1):1–24.

Pradnyaandara IGBMA, Saputra H, Dewi IGASM, Sumadi IWJ. Karakteristik Pasien Karsinoma Paru Di RSUP Sanglah Denpasar Tahun 2017-2018. Jurnal Medika Udayana. 2020;9(11):43-48.

H Möller, L Shack AM. Lung cancer in the North West of England. North West Cancer Intell Serv. 2008;16–9.

Liu S, Chen Q, Guo L, et al. Incidence and mortality of lung cancer in China, 2008−2012. Chinese J Cancer Res. 2018;30:508–87.

Vinay Kumar, Ramzi S. Cotran SLR. Buku Ajar Patologi Robbins. Patologi. 2013.

Tarigan SP, Soeroso NN, Tumanggor CAK, et al. Clinical profile of male patients with non-small cell lung cancer in Adam Malik General Hospital, Medan, Indonesia. Open Access Maced J Med Sci.

;7(16):2612–4

Badan Pusat Statistik. Stylesheet [Internet]. Persentase Merokok Pada Penduduk Umur ≥ 15 Tahun Menurut Kelompok Umur, 2015-2018. Badan Pusat Statistik; 2018. Available from: https://www.bps.go.id/dynamictable/2018/07/02/1517/persentase-merokok-padapenduduk-umur-15-tahun-menurut-kelompok-umur-2015-2018.html.

Stone SL, Anderko L, Berger M. Butler CR, et al. Wildfire Smoke: A Guide for Public Health Officials, revised 2019. U.S. EPA Office of Research and Development, Washington, DC, EPA/452/R-19/901, 2019.

Spiro SG, Gould MK, Colice GL. Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes. Chest. 2007;123:97S-104S.

Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006 Apr;83(4):735-43.

Wulandari L, Faot NE. Problem Penegakkan Diagnostik Pasien dengan Massa di Paru. J Respirasi. 2019;3(2):41−46.

Forgacs E, Zöchbauer-Müller S, Oláh E, Minna JD. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res. 2001;7(1):6-13.

Clark SB, Alsubait S. Non Small Cell Lung Cancer. [Updated 2022 Sep 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562307/


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.